Literature DB >> 17629608

Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.

Ming-de Lu1, Xiao-Ling Yu, An-Hua Li, Tian-An Jiang, Min-Hua Chen, Bao-Zhen Zhao, Xiao-Dong Zhou, Jin-Rui Wang.   

Abstract

To evaluate the ability of contrast enhanced ultrasound (CEUS) in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma (HCC) in comparison with contrast enhanced computed tomography (CECT) and/or magnetic resonance imaging (CEMRI). A total of 151 patients were enrolled in the study. Before the radio-frequency (RF) or microwave ablation treatment, tumor vascularity was assessed in 139 patients with three imaging modalities i.e., US (139 exams), CEUS (139 exams) and CECT (103 exams)/CEMR (36 exams). CEUS examination was performed using a sulphur hexafluoride-filled microbubble contrast agent (SonoVue((R)), Bracco, Milan, Italy) and real-time contrast-specific imaging techniques. Within 30 +/- 7 d after the ablation procedure, 118/139 patients were monitored to assess the tumor response to treatment. Before ablation, contrast enhancement within tumor was observed in 129/139 (92.8%) patients with CEUS and 133/139 (95.7%) patients with CECT/CEMRI. Compared with CECT/CEMRI, CEUS sensitivity and accuracy in detecting tumor vascularity were 97.0% and 94.2%, respectively. One month after treatment, no enhancement was seen in 110/118 (93.2%) both on CEUS and CECT/CEMRI. Concordance between CEUS and CECT/CEMR on the presence of residual vascularization was obtained in four patients (true positive). The specificity and accuracy of CEUS in detecting tumor vascularity were 98.2% and 96.6%, respectively. The periprocedural impact of SonoVue administration on the assessment of treatment extent was also evaluated in a subgroup of patients and CEUS showed its superiority compared with baseline US in defining treatment outcome. In conclusion, in the detection of HCC tumor vascularity and assessment of response to thermal ablation after 1 month, real time CEUS provided results comparable to those obtained with CECT/CEMRI. CEUS examination proved to be a safe and easy to access procedure, with potential for diagnostic impact in the clinical practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17629608     DOI: 10.1016/j.ultrasmedbio.2007.05.004

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  30 in total

1.  Contrast-enhanced ultrasound: The evolving applications.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2009-12-31

2.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

Review 3.  Contrast-enhanced and targeted ultrasound.

Authors:  Michiel Postema; Odd Helge Gilja
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

4.  Ultrasound Contrast Agents in the Study of Kidney Function in Health and Disease.

Authors:  Kambiz Kalantarinia; Mark D Okusa
Journal:  Drug Discov Today Dis Mech       Date:  2007

Review 5.  Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy.

Authors:  Ping Liang; Jie Yu; Ming-De Lu; Bao-Wei Dong; Xiao-Ling Yu; Xiao-Dong Zhou; Bing Hu; Ming-Xing Xie; Wen Cheng; Wen He; Jian-Wen Jia; Guo-Rong Lu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 6.  The current status of contrast-enhanced ultrasound in China.

Authors:  Hui-Xiong Xu; Ming-De Lu
Journal:  J Med Ultrason (2001)       Date:  2010-04-21       Impact factor: 1.314

7.  [Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma].

Authors:  E M Jung; W Uller; C Stroszczynski; D-A Clevert
Journal:  Radiologe       Date:  2011-06       Impact factor: 0.635

8.  Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma.

Authors:  Vincenzo O Palmieri; Daniela Santovito; Giuseppe Marano; Francesco Minerva; Lara Ricci; Felicia D'Alitto; Giuseppe Angelelli; Giuseppe Palasciano
Journal:  Radiol Med       Date:  2015-01-20       Impact factor: 3.469

9.  Hepatocellular carcinoma after ablation: the imaging follow-up scheme.

Authors:  Lin-Na Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 10.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.